Australian Clinical Labs Ltd (AU:ACL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Australian Clinical Labs Ltd has announced that First Sentier Investors Holdings Pty Limited and its ultimate parent, Mitsubishi UFJ Financial Group (MUFG), together now hold a substantial voting interest in the company as of September 12, 2024. The total number of votes from all voting shares in possession of the substantial holder is 13,986,989. This significant financial move, which includes a mix of fully paid ordinary shares and other securities, may indicate a strategic position by First Sentier and its parent MUFG within Australian Clinical Labs.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.